Bo Ahrén
331 – 340 of 393
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy
(
- Contribution to journal › Article
-
Mark
Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.
(
- Contribution to journal › Article
-
Mark
Autonomic mechanism and defects in the glucagon response to insulin-induced hypoglycaemia
(
- Contribution to journal › Article
-
Mark
The association between leptin and proinsulin is lost with central obesity.
(
- Contribution to journal › Article
-
Mark
Quantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women.
(
- Contribution to journal › Article
-
Mark
Interleukin-6-deficient mice develop mature-onset obesity
(
- Contribution to journal › Article
-
Mark
Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice.
(
- Contribution to journal › Article
-
Mark
Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model.
(
- Contribution to journal › Article
-
Mark
Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.
(
- Contribution to journal › Letter
-
Mark
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
(
- Contribution to journal › Article